Coherus BioSciences Inc (CHRS)

NASDAQ HEALTHCARE
$1.74 -1.69% RSI 48 Neutral Add Alert

Moving Averages

SMA 200
$1.44
Price above

Company Profile

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$251.82M
P/E Ratio
None
EPS
$-1.56
Beta
1.039
Dividend Yield
0.00%
52-Week High
$2.616
52-Week Low
$0.71

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 10:27 AM EDT

Track CHRS for free

Get e-mail RSI alerts when Coherus BioSciences Inc enters oversold or overbought territory. Free forever.

Add Alert